GlassScriptPhysician profile
Kandice King
NPI 1629448154
$294.12
in general payments reported to CMS, 2019-2025
9 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.53 · 2022: $12.38 · 2024: $3.69 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $156.45 | 2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $27.63 | 2022-2025 | Otezla, Repatha |
| Exact Sciences Corporation | $20.37 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $19.84 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $18.18 | 2025 | Airsupra |
| Axsome Therapeutics, INC. | $17.05 | 2025 | Auvelity |
| Genentech USA, INC. | $16.53 | 2021 | |
| Esperion Therapeutics, INC. | $14.38 | 2025 | Nexletol |
| Btg International INC. | $3.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kandice King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.